Delivery Order SPE2DB24D1107-SPE2DB24FZFP4

Award Date 8/26/24
Potential Completion Date 8/27/24
Potential Value $40K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $14,315.83 Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of JARDIANCE 25 MG TABLET 90S. The contract has an ultimate completion date of May 29, 2025 and is not set-aside. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global...
This is a firm-fixed-price delivery order awarded to Amerisourcebergen Drug Corp. by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency. The contract, valued at $72,729.03, is for the supply of JARDIANCE 25 MG TABLET 90S, a pharmaceutical product, with a period of performance through September 18, 2024. Amerisourcebergen, a major pharmaceutical distributor, is providing these medical supplies without any set-aside designation. This delivery order is likely part of a...
This is a $13,379.04 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of JARDIANCE 25 MG TABLET 90S, a pharmaceutical product, with a period of performance through February 4, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,518.10, is for the delivery of 4568700550 - JARDIANCE 25 MG TABLET 90S. The contract has an ultimate completion date of July 3, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, for the supply of JARDIANCE 25 MG TABLET 90S. The $32,779.51 Firm Fixed Price contract has an ultimate completion date of August 6, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for delivering a comprehensive range...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $25,339.80, is for the delivery of 90 tablets of the drug JARDIANCE 10 MG. The ultimate completion date for this delivery order is June 17, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This is a Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of JARDIANCE 25 MG TABLET 90S. The contract has a ceiling value of $24,617.56 and a period of performance ending on June 24, 2025. This award is not associated with a set-aside program. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $66,630.25 contract is for the supply of JARDIANCE 25 MG TABLET 90S, a prescription medication, with a period of performance through July 10, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a $10,919.15 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of JARDIANCE 25 MG TABLET 90S. The contract has an ultimate completion date of June 12, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical...
This is a $57,630.34 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of JARDIANCE 25 MG TABLET 90S, with a performance period through May 29, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support...
  • SPE2DB24D1107
    Indefinite Delivery Contract
  • SPE2DB24D1107-SPE2DB24FZFP4
    Delivery Order

This is a Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation (Amerisourcebergen) for the supply of JARDIANCE 25 MG TABLET 90S. The contract, valued at $39,686.27, has an ultimate completion date of August 27, 2024. Amerisourcebergen, a major pharmaceutical distributor, is supplying this medication through an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025. This IDC enables the DLA to efficiently procure a range of medical commodities, including prescription drugs, to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 11/25/24, 9:03 AM